As this market continues to evolve, companies that can effectively align their product offerings with the unique needs of GLP-1 users are likely to thrive
Who it's for: Patients with hormone-related symptoms, adrenal concerns, cycle irregularities, perimenopause or andropause, or those currently on hormone therapies
It is primarily determined by your lean muscle mass
Fifty of the 173 users discontinued the agents before the 1-year study period was up, most often for gastrointestinal symptoms and "insurance issues." Limitations to the study included its single-center, retrospective design and small sample size
Switched to SNRI, added short-term sleep aid, safety plan reviewed
The levels of Mmp13 , Timp1 , PAI-1 , Tgf and Col3a1 , were significantly reduced by liraglutide treatment in female SKO mice, consistent with the histological observations ( Figure 3E )